Botox® was approved in 2010 by the Medicines and Healthcare products Regulatory Agency (MHRA) for adults who get chronic migraines. Chronic migraines are defined as headaches occurring on 15 or more days each month, at least half of which have migrainous features.
In the first instance, patients who are struggling to manage their symptoms should discuss this with their general practitioner (GP) and if appropriate, seek referral to a specialist with an interest in headache disorders.
Further information on the use of Botox® for the treatment of chronic migraines can be found at The Migraine Trust.
